Literature DB >> 6391219

Proteins responsible for a punctate fluorescence pattern in Plasmodium falciparum merozoites.

R F Howard, H A Stanley, G H Campbell, R T Reese.   

Abstract

Mouse monoclonal antibodies (McAbs) have been used to characterize the proteins of the asexual erythrocytic cycle of Plasmodium falciparum. Three different McAbs react with antigens of the schizont and extracellular merozoite to give a punctate fluorescence pattern. In many cases, such areas of fluorescence were composed of two adjacent, fluorescent bodies; these were distinct from the nuclei. In contrast, McAbs which bound to the ring-stage parasite were not localized, but were diffusely distributed within or around the ring-stage parasite. These McAbs immunoprecipitated five prominent, 35S-methionine-labeled schizont proteins (p) of Mr 82K, 70K, 67K, 39K, and 37K. Only p82, p39, and p37 were immunoprecipitated from schizont-labeled ring-stage parasites; thus, it appears that p70 and p67 are modified, degraded, or secreted some time between intracellular merozoite maturation and erythrocyte invasion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6391219     DOI: 10.4269/ajtmh.1984.33.1055

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  19 in total

1.  Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Johnson; R Leke; L Harun; C Ginsberg; J Ngogang; A Stowers; A Saul; I A Quakyi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  RAP1 controls rhoptry targeting of RAP2 in the malaria parasite Plasmodium falciparum.

Authors:  D L Baldi; K T Andrews; R F Waller; D S Roos; R F Howard; B S Crabb; A F Cowman
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

3.  Induction of proliferative responses of T cells from Babesia bovis-immune cattle with a recombinant 77-kilodalton merozoite protein (Bb-1).

Authors:  C L Tetzlaff; A C Rice-Ficht; V M Woods; W C Brown
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

4.  Initial extracellular forms of Plasmodium falciparum: their ultrastructure and their definition with monoclonal antibodies.

Authors:  J M Zung; W Trager; E Gubert
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

5.  Assessment of the humoral immune response against Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Stowers; D Taylor; N Prescott; Q Cheng; J Cooper; A Saul
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

6.  In vitro inhibition of multiplication of Babesia bigemina by using monoclonal antibodies.

Authors:  J V Figueroa; G M Buening
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

7.  Identification of Babesia bovis merozoite surface antigens by using immune bovine sera and monoclonal antibodies.

Authors:  W L Goff; W C Davis; G H Palmer; T F McElwain; W C Johnson; J F Bailey; T C McGuire
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

8.  Identification and characterisation of proteins associated with the rhoptry organelles of Plasmodium falciparum merozoites.

Authors:  J T Clark; R Anand; T Akoglu; J S McBride
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

9.  Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites.

Authors:  Dave Richard; Christopher A MacRaild; David T Riglar; Jo-Anne Chan; Michael Foley; Jake Baum; Stuart A Ralph; Raymond S Norton; Alan F Cowman
Journal:  J Biol Chem       Date:  2010-03-12       Impact factor: 5.157

10.  Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.

Authors:  W A Siddiqui; L Q Tam; K J Kramer; G S Hui; S E Case; K M Yamaga; S P Chang; E B Chan; S C Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.